{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T19:06:57Z","timestamp":1791313617535,"version":"4.3.1"},"reference-count":92,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,10,22]],"date-time":"2016-10-22T00:00:00Z","timestamp":1477094400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2016,10,22]],"date-time":"2016-10-22T00:00:00Z","timestamp":1477094400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["R15GM112121"],"award-info":[{"award-number":["R15GM112121"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Biomed Sci"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1186\/s12929-016-0291-y","type":"journal-article","created":{"date-parts":[[2016,10,22]],"date-time":"2016-10-22T06:59:35Z","timestamp":1477119575000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["A disease spectrum for ITPA variation: advances in biochemical and clinical research"],"prefix":"10.1186","volume":"23","author":[{"given":"Nicholas E.","family":"Burgis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,10,22]]},"reference":[{"key":"291_CR1","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.mrgentox.2010.06.009","volume":"703","author":"K Sakumi","year":"2010","unstructured":"Sakumi K, Abolhassani N, Behmanesh M, Iyama T, Tsuchimoto D, Nakabeppu Y. ITPA protein, an enzyme that eliminates deaminated purine nucleoside triphosphates in cells. Mutat Res. 2010;703:43\u201350.","journal-title":"Mutat Res"},{"key":"291_CR2","doi-asserted-by":"publisher","first-page":"3531","DOI":"10.1074\/jbc.M608708200","volume":"282","author":"NE Burgis","year":"2007","unstructured":"Burgis NE, Cunningham RP. Substrate specificity of RdgB protein, a deoxyribonucleoside triphosphate pyrophosphohydrolase. J Biol Chem. 2007;282:3531\u20138.","journal-title":"J Biol Chem"},{"key":"291_CR3","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1107\/S1744309106041790","volume":"62","author":"J Porta","year":"2006","unstructured":"Porta J, Kolar C, Kozmin SG, Pavlov YI, Borgstahl GE. Structure of the orthorhombic form of human inosine triphosphate pyrophosphatase. Acta Crystallogr Sect F: Struct Biol Cryst Commun. 2006;62:1076\u201381.","journal-title":"Acta Crystallogr Sect F: Struct Biol Cryst Commun"},{"key":"291_CR4","doi-asserted-by":"publisher","first-page":"3182","DOI":"10.1074\/jbc.M609838200","volume":"282","author":"P Stenmark","year":"2007","unstructured":"Stenmark P, Kursula P, Flodin S, Graslund S, Landry R, Nordlund P, Schuler H. Crystal structure of human inosine triphosphatase. Substrate binding and implication of the inosine triphosphatase deficiency mutation P32T. J Biol Chem. 2007;282:3182\u20137.","journal-title":"J Biol Chem"},{"key":"291_CR5","doi-asserted-by":"publisher","first-page":"18695","DOI":"10.1074\/jbc.M011084200","volume":"276","author":"S Lin","year":"2001","unstructured":"Lin S, McLennan AG, Ying K, Wang Z, Gu S, Jin H, Wu C, Liu W, Yuan Y, Tang R, et al. Cloning, expression, and characterization of a human inosine triphosphate pyrophosphatase encoded by the ITPA gene. J Biol Chem. 2001;276:18695\u2013701.","journal-title":"J Biol Chem"},{"key":"291_CR6","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1038\/cdd.2009.53","volume":"16","author":"M Behmanesh","year":"2009","unstructured":"Behmanesh M, Sakumi K, Abolhassani N, Toyokuni S, Oka S, Ohnishi YN, Tsuchimoto D, Nakabeppu Y. ITPase-deficient mice show growth retardation and die before weaning. Cell Death Differ. 2009;16:1315\u201322.","journal-title":"Cell Death Differ"},{"key":"291_CR7","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.mrrev.2013.08.001","volume":"753","author":"PD Simone","year":"2013","unstructured":"Simone PD, Pavlov YI, Borgstahl GE. ITPA (inosine triphosphate pyrophosphatase): from surveillance of nucleotide pools to human disease and pharmacogenetics. Mutat Res. 2013;753:131\u201346.","journal-title":"Mutat Res"},{"key":"291_CR8","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/0009-8981(79)90410-8","volume":"97","author":"SL Holmes","year":"1979","unstructured":"Holmes SL, Turner BM, Hirschhorn K. Human inosine triphosphatase: catalytic properties and population studies. Clin Chim Acta. 1979;97:143\u201353.","journal-title":"Clin Chim Acta"},{"key":"291_CR9","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1111\/j.1365-2958.2005.04950.x","volume":"59","author":"MY Galperin","year":"2006","unstructured":"Galperin MY, Moroz OV, Wilson KS, Murzin AG. House cleaning, a part of good housekeeping. Mol Microbiol. 2006;59:5\u201319.","journal-title":"Mol Microbiol"},{"key":"291_CR10","first-page":"561","volume-title":"Escherichia coli and salmonella cellular and molecular biology","author":"H Zalkin","year":"1996","unstructured":"Zalkin H, Nygaard P. Biosynthesis of purine nucleotides. In: Neidhardt FC, editor. Escherichia coli and salmonella cellular and molecular biology, vol. 1. 2nd ed. Washington: ASM Press; 1996. p. 561\u201379.","edition":"2"},{"key":"291_CR11","volume-title":"DNA repair and mutagenesis","author":"EC Friedberg","year":"1995","unstructured":"Friedberg EC, Walker GC, Siede W. DNA repair and mutagenesis. Washington: American Society for Microbiology; 1995."},{"key":"291_CR12","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1038\/10745","volume":"6","author":"KY Hwang","year":"1999","unstructured":"Hwang KY, Chung JH, Kim SH, Han YS, Cho Y. Structure-based identification of a novel NTPase from Methanococcus jannaschii. Nat Struct Biol. 1999;6:691\u20136.","journal-title":"Nat Struct Biol"},{"key":"291_CR13","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1016\/j.jmb.2007.10.012","volume":"374","author":"A Savchenko","year":"2007","unstructured":"Savchenko A, Proudfoot M, Skarina T, Singer A, Litvinova O, Sanishvili R, Brown G, Chirgadze N, Yakunin AF. Molecular basis of the antimutagenic activity of the house-cleaning inosine triphosphate pyrophosphatase RdgB from Escherichia coli. J Mol Biol. 2007;374:1091\u2013103.","journal-title":"J Mol Biol"},{"key":"291_CR14","doi-asserted-by":"publisher","first-page":"3099","DOI":"10.1093\/nar\/29.14.3099","volume":"29","author":"JH Chung","year":"2001","unstructured":"Chung JH, Back JH, Park YI, Han YS. Biochemical characterization of a novel hypoxanthine\/xanthine dNTP pyrophosphatase from Methanococcus jannaschii. Nucleic Acids Res. 2001;29:3099\u2013107.","journal-title":"Nucleic Acids Res"},{"key":"291_CR15","doi-asserted-by":"publisher","first-page":"403","DOI":"10.5483\/BMBRep.2002.35.4.403","volume":"35","author":"JH Chung","year":"2002","unstructured":"Chung JH, Park HY, Lee JH, Jang Y. Identification of the dITP- and XTP-hydrolyzing protein from Escherichia coli. J Biochem Mol Biol. 2002;35:403\u20138.","journal-title":"J Biochem Mol Biol"},{"key":"291_CR16","doi-asserted-by":"publisher","first-page":"6934","DOI":"10.1128\/JVI.00537-09","volume":"83","author":"DR Mbanzibwa","year":"2009","unstructured":"Mbanzibwa DR, Tian Y, Mukasa SB, Valkonen JP. Cassava brown streak virus (Potyviridae) encodes a putative Maf\/HAM1 pyrophosphatase implicated in reduction of mutations and a P1 proteinase that suppresses RNA silencing but contains no HC-Pro. J Virol. 2009;83:6934\u201340.","journal-title":"J Virol"},{"key":"291_CR17","doi-asserted-by":"publisher","first-page":"2319","DOI":"10.1073\/pnas.1118455109","volume":"109","author":"B Pang","year":"2012","unstructured":"Pang B, McFaline JL, Burgis NE, Dong M, Taghizadeh K, Sullivan MR, Elmquist CE, Cunningham RP, Dedon PC. Defects in purine nucleotide metabolism lead to substantial incorporation of xanthine and hypoxanthine into DNA and RNA. Proc Natl Acad Sci U S A. 2012;109:2319\u201324.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"291_CR18","doi-asserted-by":"publisher","first-page":"2891","DOI":"10.1093\/nar\/gkp1250","volume":"38","author":"N Abolhassani","year":"2010","unstructured":"Abolhassani N, Iyama T, Tsuchimoto D, Sakumi K, Ohno M, Behmanesh M, Nakabeppu Y. NUDT16 and ITPA play a dual protective role in maintaining chromosome stability and cell growth by eliminating dIDP\/IDP and dITP\/ITP from nucleotide pools in mammals. Nucleic Acids Res. 2010;38:2891\u2013903.","journal-title":"Nucleic Acids Res"},{"key":"291_CR19","doi-asserted-by":"publisher","first-page":"3101","DOI":"10.1128\/JB.185.10.3101-3110.2003","volume":"185","author":"NE Burgis","year":"2003","unstructured":"Burgis NE, Brucker JJ, Cunningham RP. Repair system for noncanonical purines in Escherichia coli. J Bacteriol. 2003;185:3101\u201310.","journal-title":"J Bacteriol"},{"key":"291_CR20","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1002\/(SICI)1097-0061(199601)12:1<17::AID-YEA875>3.0.CO;2-I","volume":"12","author":"VN Noskov","year":"1996","unstructured":"Noskov VN, Staak K, Shcherbakova PV, Kozmin SG, Negishi K, Ono BC, Hayatsu H, Pavlov YI. HAM1, the gene controlling 6-N-hydroxylaminopurine sensitivity and mutagenesis in the yeast Saccharomyces cerevisiae. Yeast. 1996;12:17\u201329.","journal-title":"Yeast"},{"key":"291_CR21","doi-asserted-by":"publisher","DOI":"10.4061\/2010\/872180","author":"IS Waisertreiger","year":"2010","unstructured":"Waisertreiger IS, Menezes MR, Randazzo J, Pavlov YI. Elevated levels of DNA strand breaks induced by a base analog in the human cell line with the P32T ITPA variant. J Nucleic Acids. 2010. doi: 10.4061\/2010\/872180 .","journal-title":"J Nucleic Acids"},{"key":"291_CR22","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1093\/dnares\/12.1.39","volume":"12","author":"M Behmanesh","year":"2005","unstructured":"Behmanesh M, Sakumi K, Tsuchimoto D, Torisu K, Ohnishi-Honda Y, Rancourt DE, Nakabeppu Y. Characterization of the structure and expression of mouse Itpa gene and its related sequences in the mouse genome. DNA Res. 2005;12:39\u201351.","journal-title":"DNA Res"},{"key":"291_CR23","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1113\/jphysiol.2004.078907","volume":"563","author":"K Burton","year":"2005","unstructured":"Burton K, White H, Sleep J. Kinetics of muscle contraction and actomyosin NTP hydrolysis from rabbit using a series of metal-nucleotide substrates. J Physiol. 2005;563:689\u2013711.","journal-title":"J Physiol"},{"key":"291_CR24","volume-title":"Principles of development","author":"L Wolpert","year":"2010","unstructured":"Wolpert L, Tickle C. Principles of development. 4th ed. USA: Oxford University Press; 2010.","edition":"4"},{"key":"291_CR25","unstructured":"Voet DJ, Voet JG. Biochemistry. 3rd ed. Hoboken, NJ, USA: John Wiley & Sons, Inc.; 2008."},{"key":"291_CR26","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.abb.2003.12.017","volume":"423","author":"PC Dedon","year":"2004","unstructured":"Dedon PC, Tannenbaum SR. Reactive nitrogen species in the chemical biology of inflammation. Arch Biochem Biophys. 2004;423:12\u201322.","journal-title":"Arch Biochem Biophys"},{"key":"291_CR27","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/1756-8722-6-24","volume":"6","author":"MA Zamzami","year":"2013","unstructured":"Zamzami MA, Duley JA, Price GR, Venter DJ, Yarham JW, Taylor RW, Catley LP, Florin TH, Marinaki AM, Bowling F. Inosine triphosphate pyrophosphohydrolase (ITPA) polymorphic sequence variants in adult hematological malignancy patients and possible association with mitochondrial DNA defects. J Hematol Oncol. 2013;6:24.","journal-title":"J Hematol Oncol"},{"key":"291_CR28","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1016\/0304-4165(70)90109-1","volume":"215","author":"BS Vanderheiden","year":"1970","unstructured":"Vanderheiden BS. Human erythrocyte \u201cITPase\u201d: an ITP pyrophosphohydrolase. Biochim Biophys Acta. 1970;215:555\u20138.","journal-title":"Biochim Biophys Acta"},{"key":"291_CR29","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1002\/jcp.1040980106","volume":"98","author":"BS Vanderheiden","year":"1979","unstructured":"Vanderheiden BS. Purification and properties of human erythrocyte inosine triphosphate pyrophosphohydrolase. J Cell Physiol. 1979;98:41\u20137.","journal-title":"J Cell Physiol"},{"key":"291_CR30","first-page":"158","volume":"89","author":"A Liakopoulou","year":"1964","unstructured":"Liakopoulou A, Alivisatos SG. Distribution of nucleoside triphosphatases in human erythrocytes. Biochim Biophys Acta. 1964;89:158\u201361.","journal-title":"Biochim Biophys Acta"},{"key":"291_CR31","doi-asserted-by":"publisher","first-page":"1711","DOI":"10.1016\/j.biochi.2013.05.016","volume":"95","author":"AD Gall","year":"2013","unstructured":"Gall AD, Gall A, Moore AC, Aune MK, Heid S, Mori A, Burgis NE. Analysis of human ITPase nucleobase specificity by site-directed mutagenesis. Biochimie. 2013;95:1711\u201321.","journal-title":"Biochimie"},{"key":"291_CR32","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1002\/ana.24496","volume":"78","author":"SH Kevelam","year":"2015","unstructured":"Kevelam SH, Bierau J, Salvarinova R, Agrawal S, Honzik T, Visser D, Weiss MM, Salomons GS, Abbink TE, Waisfisz Q, et al. Recessive ITPA mutations cause an early infantile encephalopathy. Ann Neurol. 2015;78:649\u201358.","journal-title":"Ann Neurol"},{"key":"291_CR33","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.bbadis.2009.11.002","volume":"1802","author":"G Herting","year":"2010","unstructured":"Herting G, Barber K, Zappala MR, Cunningham RP, Burgis NE. Quantitative in vitro and in vivo characterization of the human P32T mutant ITPase. Biochim Biophys Acta. 2010;1802:269\u201374.","journal-title":"Biochim Biophys Acta"},{"key":"291_CR34","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.jsb.2013.03.007","volume":"182","author":"PD Simone","year":"2013","unstructured":"Simone PD, Struble LR, Kellezi A, Brown CA, Grabow CE, Khutsishvili I, Marky LA, Pavlov YI, Borgstahl GE. The human ITPA polymorphic variant P32T is destabilized by the unpacking of the hydrophobic core. J Struct Biol. 2013;182:197\u2013208.","journal-title":"J Struct Biol"},{"key":"291_CR35","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1016\/j.jmb.2009.07.051","volume":"392","author":"EI Stepchenkova","year":"2009","unstructured":"Stepchenkova EI, Tarakhovskaya ER, Spitler K, Frahm C, Menezes MR, Simone PD, Kolar C, Marky LA, Borgstahl GE, Pavlov YI. Functional study of the P32T ITPA variant associated with drug sensitivity in humans. J Mol Biol. 2009;392:602\u201313.","journal-title":"J Mol Biol"},{"key":"291_CR36","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.2217\/14622416.8.9.1221","volume":"8","author":"J Bierau","year":"2007","unstructured":"Bierau J, Lindhout M, Bakker JA. Pharmacogenetic significance of inosine triphosphatase. Pharmacogenomics. 2007;8:1221\u20138.","journal-title":"Pharmacogenomics"},{"key":"291_CR37","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1080\/15257770.2011.606789","volume":"30","author":"JA Bakker","year":"2011","unstructured":"Bakker JA, Lindhout M, Habets DD, van den Wijngaard A, Paulussen AD, Bierau J. The effect of ITPA polymorphisms on the enzyme kinetic properties of human erythrocyte inosine triphosphatase toward its substrates ITP and 6-Thio-ITP. Nucleosides Nucleotides Nucleic Acids. 2011;30:839\u201349.","journal-title":"Nucleosides Nucleotides Nucleic Acids"},{"key":"291_CR38","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.ymgme.2005.03.011","volume":"85","author":"T Maeda","year":"2005","unstructured":"Maeda T, Sumi S, Ueta A, Ohkubo Y, Ito T, Marinaki AM, Kurono Y, Hasegawa S, Togari H. Genetic basis of inosine triphosphate pyrophosphohydrolase deficiency in the Japanese population. Mol Genet Metab. 2005;85:271\u20139.","journal-title":"Mol Genet Metab"},{"key":"291_CR39","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1373\/clinchem.2005.059501","volume":"52","author":"M Shipkova","year":"2006","unstructured":"Shipkova M, Lorenz K, Oellerich M, Wieland E, von Ahsen N. Measurement of erythrocyte inosine triphosphate pyrophosphohydrolase (ITPA) activity by HPLC and correlation of ITPA genotype-phenotype in a Caucasian population. Clin Chem. 2006;52:240\u20137.","journal-title":"Clin Chem"},{"key":"291_CR40","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1007\/s00439-002-0798-z","volume":"111","author":"S Sumi","year":"2002","unstructured":"Sumi S, Marinaki AM, Arenas M, Fairbanks L, Shobowale-Bakre M, Rees DC, Thein SL, Ansari A, Sanderson J, De Abreu RA, et al. Genetic basis of inosine triphosphate pyrophosphohydrolase deficiency. Hum Genet. 2002;111:360\u20137.","journal-title":"Hum Genet"},{"key":"291_CR41","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.antiviral.2013.07.021","volume":"100","author":"A D\u2019Avolio","year":"2013","unstructured":"D\u2019Avolio A, De Nicolo A, Cusato J, Ciancio A, Boglione L, Strona S, Cariti G, Troshina G, Caviglia GP, Smedile A, et al. Association of ITPA polymorphisms rs6051702\/rs1127354 instead of rs7270101\/rs1127354 as predictor of ribavirin-associated anemia in chronic hepatitis C treated patients. Antiviral Res. 2013;100:114\u20139.","journal-title":"Antiviral Res"},{"key":"291_CR42","doi-asserted-by":"publisher","first-page":"3507","DOI":"10.1093\/hmg\/ddr249","volume":"20","author":"Y Tanaka","year":"2011","unstructured":"Tanaka Y, Kurosaki M, Nishida N, Sugiyama M, Matsuura K, Sakamoto N, Enomoto N, Yatsuhashi H, Nishiguchi S, Hino K, et al. Genome-wide association study identified ITPA\/DDRGK1 variants reflecting thrombocytopenia in pegylated interferon and ribavirin therapy for chronic hepatitis C. Hum Mol Genet. 2011;20:3507\u201316.","journal-title":"Hum Mol Genet"},{"key":"291_CR43","unstructured":"dbSNP: Short Genetic Variations. National Center for Biotechnology Information, Bethesda, MD. 2016. http:\/\/www.ncbi.nlm.nih.gov\/projects\/SNP\/snp_ref.cgi?showRare=on&chooseRs=doublehit&go=Go&locusId=3704 . Accessed 20 Oct 2016."},{"key":"291_CR44","doi-asserted-by":"publisher","first-page":"15067","DOI":"10.1038\/hgv.2015.67","volume":"3","author":"A Nakauchi","year":"2016","unstructured":"Nakauchi A, Wong JH, Mahasirimongkol S, Yanai H, Yuliwulandari R, Mabuchi A, Liu X, Mushiroda T, Wattanapokayakit S, Miyagawa T, et al. Identification of ITPA on chromosome 20 as a susceptibility gene for young-onset tuberculosis. Hum Genome Var. 2016;3:15067.","journal-title":"Hum Genome Var"},{"key":"291_CR45","doi-asserted-by":"publisher","first-page":"925","DOI":"10.2217\/pgs.16.22","volume":"17","author":"A D\u2019Avolio","year":"2016","unstructured":"D\u2019Avolio A, Cusato J, De Nicolo A, Allegra S, Di Perri G. Pharmacogenetics of ribavirin-induced anemia in HCV patients. Pharmacogenomics. 2016;17:925\u201341.","journal-title":"Pharmacogenomics"},{"key":"291_CR46","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1186\/s12967-015-0682-y","volume":"13","author":"D Pineda-Tenor","year":"2015","unstructured":"Pineda-Tenor D, Garcia-Alvarez M, Jimenez-Sousa MA, Vazquez-Moron S, Resino S. Relationship between ITPA polymorphisms and hemolytic anemia in HCV-infected patients after ribavirin-based therapy: a meta-analysis. J Transl Med. 2015;13:320.","journal-title":"J Transl Med"},{"key":"291_CR47","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1038\/clpt.2008.154","volume":"85","author":"G Stocco","year":"2009","unstructured":"Stocco G, Cheok MH, Crews KR, Dervieux T, French D, Pei D, Yang W, Cheng C, Pui CH, Relling MV, et al. Genetic polymorphism of inosine triphosphate pyrophosphatase is a determinant of mercaptopurine metabolism and toxicity during treatment for acute lymphoblastic leukemia. Clin Pharmacol Ther. 2009;85:164\u201372.","journal-title":"Clin Pharmacol Ther"},{"key":"291_CR48","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1007\/s10038-004-0183-y","volume":"49","author":"S Marsh","year":"2004","unstructured":"Marsh S, King CR, Ahluwalia R, McLeod HL. Distribution of ITPA P32T alleles in multiple world populations. J Hum Genet. 2004;49:579\u201381.","journal-title":"J Hum Genet"},{"key":"291_CR49","doi-asserted-by":"publisher","first-page":"2131","DOI":"10.1002\/hep.27009","volume":"59","author":"K Rembeck","year":"2014","unstructured":"Rembeck K, Waldenstrom J, Hellstrand K, Nilsson S, Nystrom K, Martner A, Lindh M, Norkrans G, Westin J, Pedersen C, et al. Variants of the inosine triphosphate pyrophosphatase gene are associated with reduced relapse risk following treatment for HCV genotype 2\/3. Hepatology. 2014;59:2131\u20139.","journal-title":"Hepatology"},{"key":"291_CR50","doi-asserted-by":"crossref","unstructured":"Jimmerson LC, Urban TJ, Truesdale A, Baouchi-Mokrane F, Kottilil S, Meissner EG, Sims Z, Langness JA, Hodara A, Aquilante CL et al. Variant ITPA phenotypes are associated with increased ribavirin triphosphate levels. J Clin Pharmacol. 2016. http:\/\/dx.doi.org\/10.1002\/jcph.783 .","DOI":"10.1002\/jcph.783"},{"key":"291_CR51","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1053\/j.gastro.2010.06.016","volume":"139","author":"AJ Thompson","year":"2010","unstructured":"Thompson AJ, Fellay J, Patel K, Tillmann HL, Naggie S, Ge D, Urban TJ, Shianna KV, Muir AJ, Fried MW, et al. Variants in the ITPA gene protect against ribavirin-induced hemolytic anemia and decrease the need for ribavirin dose reduction. Gastroenterology. 2010;139:1181\u20139.","journal-title":"Gastroenterology"},{"key":"291_CR52","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/nature08825","volume":"464","author":"J Fellay","year":"2010","unstructured":"Fellay J, Thompson AJ, Ge D, Gumbs CE, Urban TJ, Shianna KV, Little LD, Qiu P, Bertelsen AH, Watson M, et al. ITPA gene variants protect against anaemia in patients treated for chronic hepatitis C. Nature. 2010;464:405\u20138.","journal-title":"Nature"},{"key":"291_CR53","doi-asserted-by":"publisher","first-page":"2282","DOI":"10.1373\/clinchem.2005.057158","volume":"51","author":"N von Ahsen","year":"2005","unstructured":"von Ahsen N, Armstrong VW, Behrens C, von Tirpitz C, Stallmach A, Herfarth H, Stein J, Bias P, Adler G, Shipkova M, et al. Association of inosine triphosphatase 94C\u2009>\u2009A and thiopurine S-methyltransferase deficiency with adverse events and study drop-outs under azathioprine therapy in a prospective Crohn disease study. Clin Chem. 2005;51:2282\u20138.","journal-title":"Clin Chem"},{"key":"291_CR54","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1097\/FTD.0b013e31821a7c34","volume":"33","author":"M Shipkova","year":"2011","unstructured":"Shipkova M, Franz J, Abe M, Klett C, Wieland E, Andus T. Association between adverse effects under azathioprine therapy and inosine triphosphate pyrophosphatase activity in patients with chronic inflammatory bowel disease. Ther Drug Monit. 2011;33:321\u20138.","journal-title":"Ther Drug Monit"},{"key":"291_CR55","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.bbadis.2006.10.006","volume":"1772","author":"M Arenas","year":"2007","unstructured":"Arenas M, Duley J, Sumi S, Sanderson J, Marinaki A. The ITPA c.94C>A and g.IVS2+21A>C sequence variants contribute to missplicing of the ITPA gene. Biochim Biophys Acta. 2007;1772:96\u2013102.","journal-title":"Biochim Biophys Acta"},{"key":"291_CR56","doi-asserted-by":"publisher","first-page":"145","DOI":"10.2174\/138161210790112773","volume":"16","author":"LJ Derijks","year":"2010","unstructured":"Derijks LJ, Wong DR. Pharmacogenetics of thiopurines in inflammatory bowel disease. Curr Pharm Des. 2010;16:145\u201354.","journal-title":"Curr Pharm Des"},{"key":"291_CR57","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1007\/s00228-008-0478-6","volume":"64","author":"S Sahasranaman","year":"2008","unstructured":"Sahasranaman S, Howard D, Roy S. Clinical pharmacology and pharmacogenetics of thiopurines. Eur J Clin Pharmacol. 2008;64:753\u201367.","journal-title":"Eur J Clin Pharmacol"},{"key":"291_CR58","first-page":"A55","volume":"78","author":"M Derudas","year":"2008","unstructured":"Derudas M, McGuigan C, Brancale A, Neyts J, Balzarini J. Application of the phosphoramidate protide approach to the antiviral drug ribavirin. Antivir Res. 2008;78:A55.","journal-title":"Antivir Res"},{"key":"291_CR59","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1097\/00008571-200403000-00006","volume":"14","author":"AM Marinaki","year":"2004","unstructured":"Marinaki AM, Ansari A, Duley JA, Arenas M, Sumi S, Lewis CM, el Shobowale-Bakre M, Escuredo E, Fairbanks LD, Sanderson JD. Adverse drug reactions to azathioprine therapy are associated with polymorphism in the gene encoding inosine triphosphate pyrophosphatase (ITPase). Pharmacogenetics. 2004;14:181\u20137.","journal-title":"Pharmacogenetics"},{"key":"291_CR60","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1038\/clpt.2008.261","volume":"85","author":"Y Okada","year":"2009","unstructured":"Okada Y, Nakamura K, Hiromura K, Nojima Y, Horiuchi R, Yamamoto K. Pro32Thr polymorphism of inosine triphosphate pyrophosphatase gene predicts efficacy of low-dose azathioprine for patients with systemic lupus erythematosus. Clin Pharmacol Ther. 2009;85:527\u201330.","journal-title":"Clin Pharmacol Ther"},{"key":"291_CR61","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.cgh.2005.10.019","volume":"4","author":"Z Zelinkova","year":"2006","unstructured":"Zelinkova Z, Derijks LJ, Stokkers PC, Vogels EW, van Kampen AH, Curvers WL, Cohn D, van Deventer SJ, Hommes DW. Inosine triphosphate pyrophosphatase and thiopurine s-methyltransferase genotypes relationship to azathioprine-induced myelosuppression. Clin Gastroenterol Hepatol. 2006;4:44\u20139.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"291_CR62","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1016\/j.healun.2012.03.009","volume":"31","author":"MD Everitt","year":"2012","unstructured":"Everitt MD, Hammond ME, Snow GL, Stehlik J, Revelo MP, Miller DV, Kaza AK, Budge D, Alharethi R, Molina KM, et al. Biopsy-diagnosed antibody-mediated rejection based on the proposed International Society for Heart and Lung Transplantation working formulation is associated with adverse cardiovascular outcomes after pediatric heart transplant. J Heart Lung Transplant. 2012;31:686\u201393.","journal-title":"J Heart Lung Transplant"},{"key":"291_CR63","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1093\/aje\/kws375","volume":"177","author":"B Pasternak","year":"2013","unstructured":"Pasternak B, Svanstrom H, Schmiegelow K, Jess T, Hviid A. Use of azathioprine and the risk of cancer in inflammatory bowel disease. Am J Epidemiol. 2013;177:1296\u2013305.","journal-title":"Am J Epidemiol"},{"issue":"2","key":"291_CR64","doi-asserted-by":"crossref","first-page":"592","DOI":"10.5694\/j.1326-5377.1962.tb20590.x","volume":"49","author":"RH Bean","year":"1962","unstructured":"Bean RH. The treatment of chronic ulcerative colitis with 6-mercaptopurine. Med J Aust. 1962;49(2):592\u20133.","journal-title":"Med J Aust"},{"key":"291_CR65","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1016\/S0140-6736(69)90325-0","volume":"2","author":"BN Brooke","year":"1969","unstructured":"Brooke BN, Hoffmann DC, Swarbrick ET. Azathioprine for Crohn\u2019s disease. Lancet. 1969;2:612\u20134.","journal-title":"Lancet"},{"key":"291_CR66","doi-asserted-by":"publisher","first-page":"4787","DOI":"10.1158\/0008-5472.CAN-12-1278","volume":"72","author":"R Brem","year":"2012","unstructured":"Brem R, Karran P. Oxidation-mediated DNA cross-linking contributes to the toxicity of 6-thioguanine in human cells. Cancer Res. 2012;72:4787\u201395.","journal-title":"Cancer Res"},{"key":"291_CR67","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1038\/35101056","volume":"1","author":"MV Relling","year":"2001","unstructured":"Relling MV, Dervieux T. Pharmacogenetics and cancer therapy. Nat Rev Cancer. 2001;1:99\u2013108.","journal-title":"Nat Rev Cancer"},{"key":"291_CR68","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1126\/science.2649979","volume":"244","author":"GB Elion","year":"1989","unstructured":"Elion GB. The purine path to chemotherapy. Science. 1989;244:41\u20137.","journal-title":"Science"},{"key":"291_CR69","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1016\/j.leukres.2015.06.016","volume":"39","author":"F Azimi","year":"2015","unstructured":"Azimi F, Mortazavi Y, Alavi S, Khalili M, Ramazani A. Frequency of ITPA gene polymorphisms in Iranian patients with acute lymphoblastic leukemia and prediction of its myelosuppressive effects. Leuk Res. 2015;39:1048\u201354.","journal-title":"Leuk Res"},{"key":"291_CR70","doi-asserted-by":"publisher","first-page":"433","DOI":"10.2217\/pgs.13.226","volume":"15","author":"A Matimba","year":"2014","unstructured":"Matimba A, Li F, Livshits A, Cartwright CS, Scully S, Fridley BL, Jenkins G, Batzler A, Wang L, Weinshilboum R, Lennard L. Thiopurine pharmacogenomics: association of SNPs with clinical response and functional validation of candidate genes. Pharmacogenomics. 2014;15:433\u201347.","journal-title":"Pharmacogenomics"},{"key":"291_CR71","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1111\/j.1365-2125.2010.03867.x","volume":"71","author":"T de Beaumais Adam","year":"2011","unstructured":"de Beaumais Adam T, Fakhoury M, Medard Y, Azougagh S, Zhang D, Yakouben K, Jacqz-Aigrain E. Determinants of mercaptopurine toxicity in paediatric acute lymphoblastic leukemia maintenance therapy. Br J Clin Pharmacol. 2011;71:575\u201384.","journal-title":"Br J Clin Pharmacol"},{"key":"291_CR72","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1097\/00054725-200108000-00001","volume":"7","author":"MC Dubinsky","year":"2001","unstructured":"Dubinsky MC, Hassard PV, Seidman EG, Kam LY, Abreu MT, Targan SR, Vasiliauskas EA. An open-label pilot study using thioguanine as a therapeutic alternative in Crohn\u2019s disease patients resistant to 6-mercaptopurine therapy. Inflamm Bowel Dis. 2001;7:181\u20139.","journal-title":"Inflamm Bowel Dis"},{"key":"291_CR73","first-page":"e26","volume":"23","author":"B Al-Judaibi","year":"2016","unstructured":"Al-Judaibi B, Schwarz UI, Huda N, Dresser GK, Gregor JC, Ponich T, Chande N, Mosli M, Kim RB. Genetic predictors of azathioprine toxicity and clinical response in patients with inflammatory bowel disease. J Popul Ther Clin Pharmacol. 2016;23:e26\u201336.","journal-title":"J Popul Ther Clin Pharmacol"},{"key":"291_CR74","doi-asserted-by":"publisher","first-page":"e0137798","DOI":"10.1371\/journal.pone.0137798","volume":"10","author":"S Odahara","year":"2015","unstructured":"Odahara S, Uchiyama K, Kubota T, Ito Z, Takami S, Kobayashi H, Saito K, Koido S, Ohkusa T. A prospective study evaluating metabolic capacity of thiopurine and associated adverse reactions in Japanese patients with Inflammatory Bowel Disease (IBD). PLoS One. 2015;10:e0137798.","journal-title":"PLoS One"},{"key":"291_CR75","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.advms.2015.09.008","volume":"61","author":"R Steponaitiene","year":"2016","unstructured":"Steponaitiene R, Kupcinskas J, Survilaite S, Varkalaite G, Jonaitis L, Kiudelis G, Denapiene G, Valantinas J, Skieceviciene J, Kupcinskas L. TPMT and ITPA genetic variants in Lithuanian inflammatory bowel disease patients: Prevalence and azathioprine-related side effects. Adv Med Sci. 2016;61:135\u201340.","journal-title":"Adv Med Sci"},{"key":"291_CR76","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1186\/1471-2407-14-299","volume":"14","author":"MJ Farfan","year":"2014","unstructured":"Farfan MJ, Salas C, Canales C, Silva F, Villarroel M, Kopp K, Torres JP, Santolaya ME, Morales J. Prevalence of TPMT and ITPA gene polymorphisms and effect on mercaptopurine dosage in Chilean children with acute lymphoblastic leukemia. BMC Cancer. 2014;14:299.","journal-title":"BMC Cancer"},{"key":"291_CR77","first-page":"309","volume":"3","author":"G Stocco","year":"2012","unstructured":"Stocco G, Franca R, Verzegnassi F, Londero M, Rabusin M, Decorti G. Multilocus genotypes of relevance for drug metabolizing enzymes and therapy with thiopurines in patients with acute lymphoblastic leukemia. Front Genet. 2012;3:309.","journal-title":"Front Genet"},{"key":"291_CR78","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1097\/MEG.0b013e3283546efd","volume":"24","author":"AN Eskesen","year":"2012","unstructured":"Eskesen AN, Melum E, Moghaddam A, Bjoro K, Verbaan H, Ring-Larsen H, Dalgard O. Genetic variants at the ITPA locus protect against ribavirin-induced hemolytic anemia and dose reduction in an HCV G2\/G3 cohort. Eur J Gastroenterol Hepatol. 2012;24:890\u20136.","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"291_CR79","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1111\/j.1365-2893.2011.01564.x","volume":"19","author":"A Birerdinc","year":"2012","unstructured":"Birerdinc A, Estep M, Afendy A, Stepanova M, Younossi I, Baranova A, Younossi ZM. Gene expression profiles associated with anaemia and ITPA genotypes in patients with chronic hepatitis C (CH-C). J Viral Hepat. 2012;19:414\u201322.","journal-title":"J Viral Hepat"},{"issue":"Suppl 1","key":"291_CR80","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1111\/j.1478-3231.2008.01934.x","volume":"29","author":"D Lavanchy","year":"2009","unstructured":"Lavanchy D. The global burden of hepatitis C. Liver Int. 2009;29 Suppl 1:74\u201381.","journal-title":"Liver Int"},{"key":"291_CR81","doi-asserted-by":"publisher","first-page":"2021","DOI":"10.1515\/cclm-2015-0057","volume":"53","author":"NC Peltenburg","year":"2015","unstructured":"Peltenburg NC, Bakker JA, Vroemen WH, de Knegt RJ, Leers MP, Bierau J, Verbon A. Inosine triphosphate pyrophosphohydrolase activity: more accurate predictor for ribavirin-induced anemia in hepatitis C infected patients than ITPA genotype. Clin Chem Lab Med. 2015;53:2021\u20139.","journal-title":"Clin Chem Lab Med"},{"issue":"Suppl 1","key":"291_CR82","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000333207","volume":"84","author":"M Kudo","year":"2011","unstructured":"Kudo M. Tailor-made therapy for viral hepatitis: recent advances. Digestion. 2011;84 Suppl 1:1\u20134.","journal-title":"Digestion"},{"key":"291_CR83","doi-asserted-by":"publisher","first-page":"1587","DOI":"10.2217\/pgs.16.28","volume":"17","author":"J Ampuero","year":"2016","unstructured":"Ampuero J, Romero-Gomez M. Pharmacogenetics of ribavirin-induced anemia in hepatitis C. Pharmacogenomics. 2016;17:1587\u201394.","journal-title":"Pharmacogenomics"},{"key":"291_CR84","first-page":"e27148","volume":"15","author":"SH Chen","year":"2015","unstructured":"Chen SH, Peng CY, Lai HC, Su WP, Lin CH, Li YF, Chuang PH, Chen CH. An index to predict ribavirin-induced anemia in asian patients with chronic genotype 1 hepatitis C. Hepat Mon. 2015;15:e27148.","journal-title":"Hepat Mon"},{"key":"291_CR85","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1053\/he.2000.5789","volume":"31","author":"L De Franceschi","year":"2000","unstructured":"De Franceschi L, Fattovich G, Turrini F, Ayi K, Brugnara C, Manzato F, Noventa F, Stanzial AM, Solero P, Corrocher R. Hemolytic anemia induced by ribavirin therapy in patients with chronic hepatitis C virus infection: role of membrane oxidative damage. Hepatology. 2000;31:997\u20131004.","journal-title":"Hepatology"},{"key":"291_CR86","doi-asserted-by":"publisher","first-page":"1314","DOI":"10.1053\/j.gastro.2010.12.038","volume":"140","author":"Y Hitomi","year":"2011","unstructured":"Hitomi Y, Cirulli ET, Fellay J, McHutchison JG, Thompson AJ, Gumbs CE, Shianna KV, Urban TJ, Goldstein DB. Inosine triphosphate protects against ribavirin-induced adenosine triphosphate loss by adenylosuccinate synthase function. Gastroenterology. 2011;140:1314\u201321.","journal-title":"Gastroenterology"},{"key":"291_CR87","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1097\/FTD.0b013e3181d12f19","volume":"32","author":"S Karner","year":"2010","unstructured":"Karner S, Shi S, Fischer C, Schaeffeler E, Neurath MF, Herrlinger KR, Hofmann U, Schwab M. Determination of 6-thioguanosine diphosphate and triphosphate and nucleoside diphosphate kinase activity in erythrocytes: novel targets for thiopurine therapy? Ther Drug Monit. 2010;32:119\u201328.","journal-title":"Ther Drug Monit"},{"key":"291_CR88","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1007\/BF00521144","volume":"3","author":"BS Vanderheiden","year":"1969","unstructured":"Vanderheiden BS. Genetic studies of human erythrocyte inosine triphosphatase. Biochem Genet. 1969;3:289\u201397.","journal-title":"Biochem Genet"},{"key":"291_CR89","first-page":"540","volume-title":"Inosine triphosphate in human erytbrocytes: a genetic trait","author":"BS Vanderheiden","year":"1965","unstructured":"Vanderheiden BS. Inosine triphosphate in human erytbrocytes: a genetic trait. Stockholm: Proc 10th Congr International Society Blood Transfusion; 1965. p. 540."},{"key":"291_CR90","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1007\/BF00484239","volume":"18","author":"VL Verhoef","year":"1980","unstructured":"Verhoef VL, Fuller SA, Morris AJ. Individual variation of nucleoside triphosphate pyrophosphohydrolase activity in human erythrocytes, granulocytes, lymphocytes, and platelets. Biochem Genet. 1980;18:235\u201345.","journal-title":"Biochem Genet"},{"key":"291_CR91","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1002\/hep.24058","volume":"53","author":"F Suzuki","year":"2011","unstructured":"Suzuki F, Suzuki Y, Akuta N, Sezaki H, Hirakawa M, Kawamura Y, Hosaka T, Kobayashi M, Saito S, Arase Y, et al. Influence of ITPA polymorphisms on decreases of hemoglobin during treatment with pegylated interferon, ribavirin, and telaprevir. Hepatology. 2011;53:415\u201321.","journal-title":"Hepatology"},{"key":"291_CR92","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1038\/nchembio.186","volume":"5","author":"BD Bennett","year":"2009","unstructured":"Bennett BD, Kimball EH, Gao M, Osterhout R, Van Dien SJ, Rabinowitz JD. Absolute metabolite concentrations and implied enzyme active site occupancy in Escherichia coli. Nat Chem Biol. 2009;5:593\u20139.","journal-title":"Nat Chem Biol"}],"container-title":["Journal of Biomedical Science"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12929-016-0291-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12929-016-0291-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12929-016-0291-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,11]],"date-time":"2022-07-11T00:20:36Z","timestamp":1657498836000},"score":1,"resource":{"primary":{"URL":"https:\/\/jbiomedsci.biomedcentral.com\/articles\/10.1186\/s12929-016-0291-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10,22]]},"references-count":92,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["291"],"URL":"https:\/\/doi.org\/10.1186\/s12929-016-0291-y","relation":{},"ISSN":["1423-0127"],"issn-type":[{"value":"1423-0127","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,10,22]]},"assertion":[{"value":"29 July 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 October 2016","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 October 2016","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"73"}}